Evidence map›Paper›PMID 26198344›Full record

ArticleJournal of the International AIDS Society2015

Pre-exposure prophylaxis in Southern Africa: feasible or not?

Willem Daniel François Venter, Frances Cowan, Vivian Black, Kevin Rebe, Linda-Gail Bekker

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. PrEP implementation: moving from trials to policy and practice.Journal of the International AIDS Society · 2015
    Article
  9. PrEP Implementation Science: State-of-the-Art and Research Agenda.Journal of the International AIDS Society · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Willem Daniel François VenterWits Reproductive Health and HIV Institute (Wits RHI), University of Witwatersrand, Johannesburg, South Africa.
Frances CowanResearch Department of Infection and Population Health, University College London, London, UK.
Vivian BlackWits Reproductive Health and HIV Institute (Wits RHI), University of Witwatersrand, Johannesburg, South Africa.
Kevin RebeHealth4Men, Anova Health Institute, Cape Town, South Africa.
Linda-Gail BekkerIIDMM, UCT Health Science Faculty, Cape Town, South Africa; Linda-gail.bekker@hiv-research.org.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSouthern and Eastern Africa bear the brunt of the AIDS epidemic, and current prevention interventions remain inadequate. Antiretroviral-based pre-exposure prophylaxis (PrEP) is gaining momentum as an effective prevention intervention. DISCUSSION: Discussions have been started on how this strategy could be employed in Africa such that the populations most in need can be reached urgently for the greatest impact. This requires the selection of specific risk groups and service environments in which PrEP can be distributed safely and cost effectively while being mindful of any ethical issues.

conclusionsGiven the need for an integrated public health approach to this, a number of potential populations and opportunities for PrEP distribution exist and are discussed in this commentary.

Indexed as

Pre-Exposure ProphylaxisAfrica, SouthernAnti-HIV AgentsFemaleHIV InfectionsHumansMaleAnti-HIV AgentsAIDSHIVPrEPSouth Africa

Identifiers

PMID26198344
PMCPMC4509894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.